Serum vitamin D level - the effect on the clinical course of psoriasis.

The effect of vitamin D on clinical manifestations and activity of Behçet's disease. Postepy Dermatol Alergol (2017) 0.75

25-hydroxyvitamin D status in patients with alopecia areata. Postepy Dermatol Alergol (2017) 0.75

The relationship between severity of disease and vitamin D levels in children with atopic dermatitis. Postepy Dermatol Alergol (2017) 0.75

Vitamin D regulation of the renin-angiotensin system. J Cell Biochem (2003) 1.88

Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol (2012) 1.84

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. J Drugs Dermatol (2013) 1.07

Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol (2013) 0.96

Gene expression profiles in dendritic cells conditioned by 1alpha,25-dihydroxyvitamin D3 analog. J Steroid Biochem Mol Biol (2004) 0.95

The future of vitamin D analogs. Front Physiol (2014) 0.93

A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ (1985) 0.89

Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle (2013) 0.89

Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol (2014) 0.88

Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol (2013) 0.88

Polymorphism of the vitamin D(3) receptor in patients with psoriasis. Arch Dermatol Res (2002) 0.87

Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review. Semin Arthritis Rheum (2012) 0.86

Vitamin D analogs as therapeutic agents: a clinical study update. Curr Opin Investig Drugs (2004) 0.86

1α,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol (2013) 0.85

Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation. Acta Derm Venereol (2014) 0.82

The measurement and analysis of normal incidence solar UVB radiation and its application to the photoclimatherapy protocol for psoriasis at the Dead Sea, Israel. Photochem Photobiol (2010) 0.81

A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol (2013) 0.80

Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol (2013) 0.79

Newer targeted therapies in psoriasis. Indian J Dermatol Venereol Leprol (2013) 0.79

Vitamin D and psoriasis pathology in the Mediterranean region, Valencia (Spain). Int J Environ Res Public Health (2014) 0.78

MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways. Toxicol Lett (2011) 0.78

Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010. J Dermatol (2013) 0.78

Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3. J Am Acad Dermatol (2013) 0.77

Carotid intima-media thickness in patients with mild or moderate psoriasis. Postepy Dermatol Alergol (2016) 0.78

Pruritus ani and perianal eczema as a manifestation of systemic contact dermatitis. Postepy Dermatol Alergol (2017) 0.75